Asthma Clinical Trial
Official title:
Role of Eosinophils in the Proliferation of ASM Cells in Asthma
Being a key player in Asthma, eosinophils constitute a potential target to interfere with the series of biological events leading to Asthma pathogenesis. In this proposal, the investigators hypothesize that the interaction between eosinophils and airway smooth muscle cells (ASM) cells plays an important role in airway remodeling. Hence the investigators will investigate the role of eosinophils in enhancing ASM cells proliferation resulting in airways remodeling. The investigators will also investigate the mechanism behind this phenomenon. This will then pave the way for medical (drug) interference at one or several sites in order to prevent one of the main potential reasons behind airway remodeling, namely eosinophil-derived ASM proliferation.
Rational and hypothesis Asthma is a chronic inflammatory disorder of the lung airways that
is associated with airway remodeling and hyperresponsiveness (AHR). Its is well documented
that the smooth muscle mass in asthmatic airways is increased due to hypertrophy and
hyperplasia of the ASM cells. Moreover, eosinophils have been proposed in different studies
to play a major role in airway remodeling. The association between increased eosinophil
numbers and asthma severity has been well documented. Here, we hypothesized that the
interaction between eosinophils and ASM cells plays an important role in airway remodeling
and that eosinophils modulate the airways through enhancing ASM cell proliferation.
Objectives of the study The aim of this study is to examine the effect of eosinophils on ASM
cell proliferation using eosinophils isolated from asthmatic subjects.
Specific aim 1. Effect of co-culture of ASM cells with eosinophils on ASM cell
proliferation.
In this specific aim, the effect of eosinophil on ASM cell proliferation will be studied by
co-culturing eosinophils isolated from asthmatic and healthy patients with ASM cells in
vitro. This will be done using non-stimulated eosinophils or eosinophils activated with
Interleukin-5 (IL-5)and Interleukin-3 (IL-3). ASM proliferation will be monitored by
determining the levels of the proliferation marker Ki-67 expression in ASM cells.
Specific aim 2. Understanding the mechanism by which eosinophils enhance ASM proliferation.
In this specific aim, we will study the mechanism by which eosinophils enhance the
proliferation of ASM cells. To study if this effect of eosinophils is done through direct
contact with ASM cells, we will co-culture ASM cells with eosinophils membrane fractions.
Moreover, we will examine the effect of cytokines and extracellular matrix (ECM) proteins
produced by eosinophils on smooth muscle cells
;
Observational Model: Case Control
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|